MutSig results for CESC

Number of individuals: 36

Summary of findings

Significantly mutated genes (q≤0.1)7
Mutations seen in COSMIC0
Significantly mutated genes on COSMIC territory0
Genes with clustered mutations (≤3 aa apart)0
Significantly mutated genesets67
. . . . . . . . . (excluding sig.mutated genes)19

Mutation preprocessing

Read 36 MAFs of type "Broad"
Total number of mutations in input MAFs: 10009
After removing 2687 noncoding mutations: 7322
After collapsing adjacent/redundant mutations: 7307

Please see MutSigPreprocess "stdout.txt" for full details.

Mutation filtering

Number of mutations before filtering:		7307
After removing 57 mutations outside gene set: 7250
After removing 2049 mutations outside category set: 5201

Please see MutSigRun "stdout.txt" for full details.

Final mutation list

Final set of mutations used in analysis

Mutation breakdown by type

typecount
Frame_Shift_Del20
Frame_Shift_Ins17
In_Frame_Del9
In_Frame_Ins1
Missense_Mutation3422
Nonsense_Mutation330
Nonstop_Mutation7
Silent1335
Splice_Site60
Total5201

Nonsilent mutations: categories and mutation rates

categorynNraterate_per_mbrelative_rate
(A/T)p*A->T381212,530,6081.79e-061.790.51
(A/T)p*N->nonflip1231472,118,5442.61e-062.610.74
(C/G)p*N->mut1582623,521,1882.54e-062.540.72
(A/T)p*C->G228259,587,9368.78e-070.880.25
indel+null4381,095,639,7684.00e-070.400.11
double_null61,095,639,7685.48e-090.00550.0016
Total38661,095,639,7683.53e-063.531.00

Target coverage for each individual



(click for higher-resolution version)

Mutation counts, total coverage, and mutation rates for each individual



(click for higher-resolution version)
(click for tabular version)

Significantly mutated genes

rankgenedescriptionNnnpatnsitensiln1n2n3n4n5n6pq
1PIK3CAphosphoinositide-3-kinase, catalytic, alpha polypeptide11833297305040005.45e-080.00098
2NFE2L2nuclear factor (erythroid-derived 2)-like 26440455400311001.89e-060.014
3MLL3myeloid/lymphoid or mixed-lineage leukemia 353319687820110422.27e-060.014
4POU4F1POU class 4 homeobox 12714433200010203.09e-060.014
5OR5H6olfactory receptor, family 5, subfamily H, member 63535233300020100.0000230.074
6AQP2aquaporin 2 (collecting duct)2937633302010000.0000240.074
7FCRL1Fc receptor-like 14802433300201000.0000380.098
8TMEM51transmembrane protein 512772033300210000.0000720.15
9COL11A2collagen, type XI, alpha 218288044400021100.0000800.15
10DNAJB1DnaJ (Hsp40) homolog, subfamily B, member 13726043400210100.0000840.15
11CDK11B5360433310110100.0000920.15
12NFYBnuclear transcription factor Y, beta2347222100000200.000110.16
13SIGLEC10sialic acid binding Ig-like lectin 107696833300030000.000120.17
14MAPK1mitogen-activated protein kinase 13571233100300000.000170.21
15C15orf56chromosome 15 open reading frame 56529211100000100.000170.21
16ZIC3Zic family member 3 heterotaxy 1 (odd-paired homolog, Drosophila)3700822200010100.000270.30
17SUMO1SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)1173622200011000.000290.30
18DALRD3DALR anticodon binding domain containing 35277632310021000.000300.30
19MYH9myosin, heavy chain 9, non-muscle21754854510120200.000330.30
20TIE1tyrosine kinase with immunoglobulin-like and EGF-like domains 111815243400120100.000340.30
21HSD17B4hydroxysteroid (17-beta) dehydrogenase 48305233320200100.000350.30
22PTPN13protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)26708455510131000.000390.32
23PTENphosphatase and tensin homolog (mutated in multiple advanced cancers 1)4492822200000200.000430.33
24B2Mbeta-2-microglobulin1339222200100100.000440.33
25SPANXN5SPANX family, member N5817211100000100.000450.33
26MTA2metastasis associated 1 family, member 27484422201000100.000490.34
27B3GNT8UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 84312822200100100.000510.34
28PRRG1proline rich Gla (G-carboxyglutamic acid) 12408422200100100.000560.35
29ARHGAP6Rho GTPase activating protein 68949633310210000.000560.35
30MUC17mucin 17, cell surface associated48722466620140100.000590.35

(click for full table with 18033 genes)

Notes
N = number of sequenced bases in this gene across the individual set
n = number of (nonsilent) mutations in this gene across the individual set
npat = number of patients (individuals) with at least one nonsilent mutation
nsite = number of unique sites having a nonsilent mutation
nsil = number of silent mutations in this gene across the individual set
n1 = number of nonsilent mutations of type "(A/T)p*A->T"
n2 = number of nonsilent mutations of type "(A/T)p*N->nonflip"
n3 = number of nonsilent mutations of type "(C/G)p*N->mut"
n4 = number of nonsilent mutations of type "(A/T)p*C->G"
n5 = number of nonsilent mutations of type "indel+null"
n6 = number of nonsilent mutations of type "double_null"
null = mutation category that includes nonsense, frameshift, splice-site mutations
p_classic = p-value for the observed amount of nonsilent mutations being elevated in this gene
p_ns_s = p-value for the observed nonsilent/silent ratio being elevated in this gene
p_ks = p-value for clustering of mutations (Kolmogorov-Smirnoff test)
p_cons = p-value for enrichment of mutations at evolutionarily most-conserved sites in gene
p_joint = p-value for clustering + conservation
p = p-value (overall)
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)


Gene-gene correlations / anti-correlations

gene1gene2pqrelationship
PIK3CAPOU4F10.0900.67none
NFE2L2OR5H60.170.67none
AQP2FCRL10.240.67none
FCRL1OR5H60.240.67none
OR5H6POU4F10.240.67none
MLL3NFE2L20.240.67none
NFE2L2PIK3CA0.320.67none
FCRL1NFE2L20.370.67none
NFE2L2POU4F10.370.67none
MLL3OR5H60.490.67none
MLL3POU4F10.490.67none
AQP2MLL30.510.67none
AQP2PIK3CA0.510.67none
FCRL1MLL30.510.67none
FCRL1PIK3CA0.510.67none
OR5H6PIK3CA0.510.67none
MLL3PIK3CA0.590.72none
AQP2NFE2L20.630.73none
AQP2OR5H60.760.76none
AQP2POU4F10.760.76none
FCRL1POU4F10.760.76none

(click for full table with 21 gene-gene pairs)

Notes
p = probability of obtaining the observed degree of correlation or anti-correlation
between the given pair of genes, calculated by performing many random permutations of the
gene labels on the mutations in the dataset, thereby controling for sample-specific
and gene-specific mutation rates.
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure), correcting for the
multiple hypotheses (one hypothesis per pair of genes considered.)


COSMIC analyses

Two distinct analyses are reported using the COSMIC database:
(COS1) COSMIC used as a filter to increase power by restricting the territory of each gene
(COS2) COSMIC used as a prior for the importance of a gene

(COS1) Significantly mutated genes (COSMIC territory only)

rankgenedescriptionncosn_cosN_coscos_evpq

(click for full table with 4520 genes)

Notes
n = number of mutations in this gene in the individual set
cos = number of unique mutated sites in this gene in COSMIC
n_cos = overlap between n and cos
N_cos = number of individuals × cos
cos_ev = total evidence: number of reports in COSMIC for mutations seen in this gene
p = p-value for seeing the observed amount of overlap in this gene
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)

(COS2) Genes mutated at sites that are highly reported in COSMIC

rankgenedescriptionncosn_coscos_ev

(click for full table with 4520 genes)

Notes
n = number of mutations in this gene in the individual set
cos = number of unique mutated sites in this gene in COSMIC
n_cos = overlap between n and cos
cos_ev = total evidence: number of reports in COSMIC for mutations seen in this gene

Mutations reported in COSMIC

patientchrstartendtypegeneProtein_Changen_cos

(click for full table with 0 mutations)


Genes with clustered mutations

rankgenedescnmindistnpairs3npairs12
1FAT2FAT tumor suppressor homolog 2 (Drosophila)4246500
2A2Malpha-2-macroglobulin2Inf00
3AATFapoptosis antagonizing transcription factor2Inf00
4ABCA10ATP-binding cassette, sub-family A (ABC1), member 102Inf00
5ABCA12ATP-binding cassette, sub-family A (ABC1), member 124Inf00
6ABCA8ATP-binding cassette, sub-family A (ABC1), member 82Inf00
7ABCC3ATP-binding cassette, sub-family C (CFTR/MRP), member 32Inf00
8ABCD4ATP-binding cassette, sub-family D (ALD), member 42Inf00
9ABRactive BCR-related gene2Inf00
10ACACBacetyl-Coenzyme A carboxylase beta2Inf00
11ACAP13Inf00
12ACAP22Inf00
13ADAMTS1ADAM metallopeptidase with thrombospondin type 1 motif, 13Inf00
14ADAMTS16ADAM metallopeptidase with thrombospondin type 1 motif, 162Inf00
15ADAMTS20ADAM metallopeptidase with thrombospondin type 1 motif, 202Inf00
16ADCY10adenylate cyclase 10 (soluble)2Inf00
17ADCY9adenylate cyclase 92Inf00
18AGBL5ATP/GTP binding protein-like 54Inf00
19AHNAK2AHNAK nucleoprotein 25Inf00
20AK7adenylate kinase 72Inf00
21AKAP3A kinase (PRKA) anchor protein 32Inf00
22ALCAMactivated leukocyte cell adhesion molecule2Inf00
23ALPK2alpha-kinase 22Inf00
24ALS2amyotrophic lateral sclerosis 2 (juvenile)2Inf00
25ANAPC1anaphase promoting complex subunit 13Inf00
26ANK1ankyrin 1, erythrocytic3Inf00
27ANK3ankyrin 3, node of Ranvier (ankyrin G)2Inf00
28ANKRD26ankyrin repeat domain 262Inf00
29ANKRD30Aankyrin repeat domain 30A2Inf00
30ANKS1Aankyrin repeat and sterile alpha motif domain containing 1A2Inf00

(click for full table with 3087 genes)

Notes
n = number of mutations in this gene in the individual set
mindist = distance (in aa) between closest pair of mutations in this gene
npairs3 = how many pairs of mutations are within 3 aa of each other
npairs12 = how many pairs of mutations are within 12 aa of each other


Significantly mutated genesets

rankgenesetdescriptiongenesN_genesmut_tallyNnnpatnsitensiln1n2n3n4n5n6pq
1HSA04510_FOCAL_ADHESIONGenes involved in focal adhesionACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, ARHGAP5, BAD, BCAR1, BCL2, BIRC2, BIRC3, BIRC4, BRAF, CAPN2, CAV1, CAV2, CAV3, CCND1, CCND2, CCND3, CDC42, CHAD, COL11A1, COL11A2, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL4A4, COL4A6, COL5A1, COL5A2, COL5A3, COL6A1, COL6A2, COL6A3, COL6A6, COMP, CRK, CRKL, CTNNB1, DIAPH1, DOCK1, EGF, EGFR, ELK1, ERBB2, FARP2, FIGF, FLNA, FLNB, FLNC, FLT1, FN1, FYN, GRB2, GRLF1, GSK3B, HGF, HRAS, IBSP, IGF1, IGF1R, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAV, ITGB1, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, JUN, KDR, LAMA1, LAMA2, LAMA3, LAMA4, LAMA5, LAMB1, LAMB2, LAMB3, LAMB4, LAMC1, LAMC2, LAMC3, LOC653852, MAP2K1, MAPK1, MAPK10, MAPK3, MAPK8, MAPK9, MET, MLCK, MRCL3, MRLC2, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PARVA, PARVB, PARVG, PDGFA, PDGFB, PDGFC, PDGFD, PDGFRA, PDGFRB, PDPK1, PGF, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP5K1C, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PRKCA, PRKCB1, PRKCG, PTEN, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RAP1A, RAP1B, RAPGEF1, RELN, RHOA, ROCK1, ROCK2, SHC1, SHC2, SHC3, SHC4, SOS1, SOS2, SPP1, SRC, THBS1, THBS2, THBS3, THBS4, TLN1, TLN2, TNC, TNN, TNR, TNXB, VASP, VAV1, VAV2, VAV3, VCL, VEGFA, VEGFB, VEGFC, VTN, VWF, ZYX192ACTN1(1), ACTN3(1), ACTN4(1), AKT3(1), BRAF(1), COL11A2(4), COL1A2(2), COL3A1(1), COL4A1(1), COL5A1(1), COL5A3(2), COL6A3(2), COMP(1), EGFR(1), ERBB2(1), FLNA(2), FLNC(1), FN1(2), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), ITGAV(1), LAMA1(2), LAMA2(1), LAMA4(1), LAMA5(1), LAMB1(1), LAMB2(1), LAMB3(1), MAPK1(3), PAK2(1), PAK3(1), PDGFC(1), PIK3CA(9), PIK3CD(1), PIK3CG(1), PIK3R1(1), PPP1CB(1), PPP1R12A(3), PRKCA(1), PTEN(2), PTK2(1), RELN(2), RHOA(1), ROCK1(3), ROCK2(2), SOS1(1), SOS2(1), TNC(2), TNXB(2), VWF(1)20561688823074187273231303.97e-092.44e-06
2HSA04810_REGULATION_ OF_ACTIN_CYTOSKELETONGenes involved in regulation of actin cytoskeletonABI2, ACTN1, ACTN2, ACTN3, ACTN4, APC, APC2, ARAF, ARHGEF1, ARHGEF12, ARHGEF4, ARHGEF6, ARHGEF7, ARPC1A, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5, ARPC5L, BAIAP2, BCAR1, BDKRB1, BDKRB2, BRAF, C3orf10, CD14, CDC42, CFL1, CFL2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CRK, CRKL, CSK, CYFIP1, CYFIP2, DIAPH1, DIAPH2, DIAPH3, DOCK1, EGF, EGFR, EZR, F2, F2R, FGD1, FGD3, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF22, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR1, FGFR2, FGFR3, FGFR4, FN1, GIT1, GNA12, GNA13, GNG12, GRLF1, GSN, HRAS, INS, IQGAP1, IQGAP2, IQGAP3, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAD, ITGAE, ITGAL, ITGAM, ITGAV, ITGAX, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, KRAS, LIMK1, LIMK2, LOC200025, LOC645126, LOC653888, MAP2K1, MAP2K2, MAPK1, MAPK3, MLCK, MOS, MRAS, MRCL3, MRLC2, MSN, MYH10, MYH14, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, NCKAP1, NCKAP1L, NRAS, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PDGFA, PDGFB, PDGFRA, PDGFRB, PFN1, PFN2, PFN3, PFN4, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP4K2A, PIP4K2B, PIP4K2C, PIP5K1A, PIP5K1B, PIP5K1C, PIP5K3, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PPP1R12B, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RDX, RHOA, ROCK1, ROCK2, RRAS, RRAS2, SCIN, SLC9A1, SOS1, SOS2, SSH1, SSH2, SSH3, TIAM1, TIAM2, TMSB4X, TMSB4Y, TMSL3, VAV1, VAV2, VAV3, VCL, WAS, WASF1, WASF2, WASL203ACTN1(1), ACTN3(1), ACTN4(1), APC(3), ARHGEF6(1), ARPC5(1), BRAF(1), CYFIP1(1), DIAPH3(2), EGFR(1), EZR(1), F2R(1), FGF17(1), FGF2(1), FGF9(1), FN1(2), GNA13(1), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), ITGAE(1), ITGAM(2), ITGAV(1), KRAS(1), LIMK1(1), MAPK1(3), MYH10(2), MYH14(2), MYH9(5), NCKAP1(1), NCKAP1L(1), PAK2(1), PAK3(1), PIK3CA(9), PIK3CD(1), PIK3CG(1), PIK3R1(1), PIP5K1A(1), PPP1CB(1), PPP1R12A(3), PTK2(1), RHOA(1), ROCK1(3), ROCK2(2), SLC9A1(2), SOS1(1), SOS2(1), SSH2(1), SSH3(1), TIAM1(1), WASF2(1)15386760812973289292351501.29e-070.000040
3HSA04320_DORSO_VENTRAL_ AXIS_FORMATIONGenes involved in dorso-ventral axis formationBRAF, CPEB1, EGFR, ERBB2, ERBB4, ETS1, ETS2, ETV6, ETV7, FMN2, GRB2, KRAS, MAP2K1, MAPK1, MAPK3, NOTCH1, NOTCH2, NOTCH3, NOTCH4, PIWIL1, PIWIL2, PIWIL3, PIWIL4, RAF1, SOS1, SOS2, SPIRE1, SPIRE228BRAF(1), EGFR(1), ERBB2(1), FMN2(1), KRAS(1), MAPK1(3), NOTCH1(6), NOTCH2(2), NOTCH4(1), PIWIL1(2), PIWIL3(1), PIWIL4(2), SOS1(1), SOS2(1)291704424172232881500.0000140.0024
4ST_INTEGRIN_SIGNALING_ PATHWAYIntegrins are transmembrane receptors that mediate cell growth, survival, and migration by binding to ligands in the extracellular matrix.ABL1, ACK1, ACTN1, ACTR2, ACTR3, AKT1, AKT2, AKT3, ANGPTL2, ARHGEF6, ARHGEF7, BCAR1, BRAF, CAV1, CDC42, CDKN2A, CRK, CSE1L, DDEF1, DOCK1, EPHB2, FYN, GRAF, GRB2, GRB7, GRF2, GRLF1, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGB3BP, MAP2K4, MAP2K7, MAP3K11, MAPK1, MAPK10, MAPK8, MAPK8IP1, MAPK8IP2, MAPK8IP3, MAPK9, MRAS, MYLK, MYLK2, P4HB, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PIK3CA, PIK3CB, PKLR, PLCG1, PLCG2, PTEN, PTK2, RAF1, RALA, RHO, ROCK1, ROCK2, SHC1, SOS1, SOS2, SRC, TERF2IP, TLN1, TLN2, VASP, WAS, ZYX78ABL1(1), ACTN1(1), AKT3(1), ARHGEF6(1), BRAF(1), EPHB2(1), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), MAPK1(3), PAK2(1), PAK3(1), PIK3CA(9), PLCG2(1), PTEN(2), PTK2(1), ROCK1(3), ROCK2(2), SOS1(1), SOS2(1)67626723721299612101800.0000160.0024
5HSA04670_LEUKOCYTE_ TRANSENDOTHELIAL_ MIGRATIONGenes involved in Leukocyte transendothelial migrationACTN1, ACTN2, ACTN3, ACTN4, ARHGAP5, BCAR1, CD99, CDC42, CDH5, CLDN1, CLDN10, CLDN11, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN2, CLDN20, CLDN22, CLDN23, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9, CTNNA1, CTNNA2, CTNNA3, CTNNB1, CTNND1, CXCL12, CXCR4, CYBA, CYBB, ESAM, EZR, F11R, GNAI1, GNAI2, GNAI3, GRLF1, ICAM1, ITGA4, ITGAL, ITGAM, ITGB1, ITGB2, ITK, JAM2, JAM3, MAPK11, MAPK12, MAPK13, MAPK14, MLLT4, MMP2, MMP9, MRCL3, MRLC2, MSN, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLPF, NCF1, NCF2, NCF4, NOX1, NOX3, OCLN, PECAM1, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PLCG1, PLCG2, PRKCA, PRKCB1, PRKCG, PTK2, PTK2B, PTPN11, PXN, RAC1, RAC2, RAP1A, RAP1B, RAPGEF3, RAPGEF4, RASSF5, RHOA, RHOH, ROCK1, ROCK2, SIPA1, THY1, TXK, VASP, VAV1, VAV2, VAV3, VCAM1, VCL109ACTN1(1), ACTN3(1), ACTN4(1), CLDN18(1), CTNNA1(1), CTNNA2(2), CTNNA3(2), EZR(1), GNAI2(1), GRLF1(1), ITGA4(1), ITGAM(2), NOX1(1), NOX3(1), PIK3CA(9), PIK3CD(1), PIK3CG(1), PIK3R1(1), PLCG2(1), PRKCA(1), PTK2(1), RHOA(1), ROCK1(3), ROCK2(2)69353643820321488152500.0000440.0046
6NOTCHPATHWAYProteolysis and Signaling Pathway of NotchADAM17, DLL1, FURIN, NOTCH1, PSEN1, RBPSUH5ADAM17(1), DLL1(1), NOTCH1(6), PSEN1(2)5378401071020350200.0000440.0046
7SIG_CHEMOTAXISGenes related to chemotaxisACTR2, ACTR3, AKT1, AKT2, AKT3, ANGPTL2, ARHGAP1, ARHGAP4, ARHGEF11, BTK, CDC42, CFL1, CFL2, GDI1, GDI2, INPPL1, ITPR1, ITPR2, ITPR3, LIMK1, MYLK, MYLK2, P101-PI3K, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PDK1, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PITX2, PPP1R13B, PTEN, RACGAP1, RHO, ROCK1, ROCK2, RPS4X, SAG, WASF1, WASL44AKT3(1), ARHGAP4(2), ARHGEF11(1), BTK(1), GDI1(1), ITPR2(1), LIMK1(1), PAK2(1), PAK3(1), PDK1(1), PIK3CA(9), PIK3CD(1), PIK3CG(1), PIK3R1(1), PTEN(2), ROCK1(3), ROCK2(2), RPS4X(1), SAG(1)3887316321726264161500.0000710.0052
8SA_PTEN_PATHWAYPTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate.AKT1, AKT2, AKT3, BPNT1, GRB2, ILK, MAPK1, MAPK3, PDK1, PIK3CA, PIK3CD, PIP3-E, PTEN, PTK2B, RBL2, SHC1, SOS116AKT3(1), MAPK1(3), PDK1(1), PIK3CA(9), PIK3CD(1), PTEN(2), RBL2(1), SOS1(1)111434419111105570200.0000720.0052
9MTORPATHWAYMammalian target of rapamycin (mTOR) senses mitogenic factors and nutrients, including ATP, and induces cell proliferation.AKT1, EIF3S10, EIF4A1, EIF4A2, EIF4B, EIF4E, EIF4EBP1, EIF4G1, EIF4G2, EIF4G3, FKBP1A, FRAP1, MKNK1, PDK2, PDPK1, PIK3CA, PIK3R1, PPP2CA, PTEN, RPS6, RPS6KB1, TSC1, TSC221EIF4A1(1), EIF4B(1), EIF4G1(3), MKNK1(1), PIK3CA(9), PIK3R1(1), PTEN(2), TSC1(1), TSC2(1)151556420121436390200.0000770.0052
10ARENRF2PATHWAYNrf1 and nrf2 are transcription factors that bind to antioxidant response elements (AREs), promoters of genes involved in oxidative damage control.CREB1, FOS, FXYD2, JUN, KEAP1, MAFF, MAFG, MAFK, MAPK1, MAPK14, MAPK8, NFE2L2, PRKCA, PRKCB112MAPK1(3), NFE2L2(5), PRKCA(1)48207698600711000.000120.0074

(click for full table with 616 genesets)

Notes: (Please see notes under significantly mutated gene table)


Significantly mutated genesets (excluding significantly mutated genes)

rankgenesetdescriptiongenesN_genesmut_tallyNnnpatnsitensiln1n2n3n4n5n6pq
1HSA04810_REGULATION_ OF_ACTIN_CYTOSKELETONGenes involved in regulation of actin cytoskeletonABI2, ACTN1, ACTN2, ACTN3, ACTN4, APC, APC2, ARAF, ARHGEF1, ARHGEF12, ARHGEF4, ARHGEF6, ARHGEF7, ARPC1A, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5, ARPC5L, BAIAP2, BCAR1, BDKRB1, BDKRB2, BRAF, C3orf10, CD14, CDC42, CFL1, CFL2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CRK, CRKL, CSK, CYFIP1, CYFIP2, DIAPH1, DIAPH2, DIAPH3, DOCK1, EGF, EGFR, EZR, F2, F2R, FGD1, FGD3, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF22, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR1, FGFR2, FGFR3, FGFR4, FN1, GIT1, GNA12, GNA13, GNG12, GRLF1, GSN, HRAS, INS, IQGAP1, IQGAP2, IQGAP3, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAD, ITGAE, ITGAL, ITGAM, ITGAV, ITGAX, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, KRAS, LIMK1, LIMK2, LOC200025, LOC645126, LOC653888, MAP2K1, MAP2K2, MAPK1, MAPK3, MLCK, MOS, MRAS, MRCL3, MRLC2, MSN, MYH10, MYH14, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, NCKAP1, NCKAP1L, NRAS, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PDGFA, PDGFB, PDGFRA, PDGFRB, PFN1, PFN2, PFN3, PFN4, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP4K2A, PIP4K2B, PIP4K2C, PIP5K1A, PIP5K1B, PIP5K1C, PIP5K3, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PPP1R12B, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RDX, RHOA, ROCK1, ROCK2, RRAS, RRAS2, SCIN, SLC9A1, SOS1, SOS2, SSH1, SSH2, SSH3, TIAM1, TIAM2, TMSB4X, TMSB4Y, TMSL3, VAV1, VAV2, VAV3, VCL, WAS, WASF1, WASF2, WASL202ACTN1(1), ACTN3(1), ACTN4(1), APC(3), ARHGEF6(1), ARPC5(1), BRAF(1), CYFIP1(1), DIAPH3(2), EGFR(1), EZR(1), F2R(1), FGF17(1), FGF2(1), FGF9(1), FN1(2), GNA13(1), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), ITGAE(1), ITGAM(2), ITGAV(1), KRAS(1), LIMK1(1), MAPK1(3), MYH10(2), MYH14(2), MYH9(5), NCKAP1(1), NCKAP1L(1), PAK2(1), PAK3(1), PIK3CD(1), PIK3CG(1), PIK3R1(1), PIP5K1A(1), PPP1CB(1), PPP1R12A(3), PTK2(1), RHOA(1), ROCK1(3), ROCK2(2), SLC9A1(2), SOS1(1), SOS2(1), SSH2(1), SSH3(1), TIAM1(1), WASF2(1)15268428722770284291951501.67e-060.00052
2HSA04510_FOCAL_ADHESIONGenes involved in focal adhesionACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, ARHGAP5, BAD, BCAR1, BCL2, BIRC2, BIRC3, BIRC4, BRAF, CAPN2, CAV1, CAV2, CAV3, CCND1, CCND2, CCND3, CDC42, CHAD, COL11A1, COL11A2, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL4A4, COL4A6, COL5A1, COL5A2, COL5A3, COL6A1, COL6A2, COL6A3, COL6A6, COMP, CRK, CRKL, CTNNB1, DIAPH1, DOCK1, EGF, EGFR, ELK1, ERBB2, FARP2, FIGF, FLNA, FLNB, FLNC, FLT1, FN1, FYN, GRB2, GRLF1, GSK3B, HGF, HRAS, IBSP, IGF1, IGF1R, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAV, ITGB1, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, JUN, KDR, LAMA1, LAMA2, LAMA3, LAMA4, LAMA5, LAMB1, LAMB2, LAMB3, LAMB4, LAMC1, LAMC2, LAMC3, LOC653852, MAP2K1, MAPK1, MAPK10, MAPK3, MAPK8, MAPK9, MET, MLCK, MRCL3, MRLC2, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PARVA, PARVB, PARVG, PDGFA, PDGFB, PDGFC, PDGFD, PDGFRA, PDGFRB, PDPK1, PGF, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP5K1C, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PRKCA, PRKCB1, PRKCG, PTEN, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RAP1A, RAP1B, RAPGEF1, RELN, RHOA, ROCK1, ROCK2, SHC1, SHC2, SHC3, SHC4, SOS1, SOS2, SPP1, SRC, THBS1, THBS2, THBS3, THBS4, TLN1, TLN2, TNC, TNN, TNR, TNXB, VASP, VAV1, VAV2, VAV3, VCL, VEGFA, VEGFB, VEGFC, VTN, VWF, ZYX191ACTN1(1), ACTN3(1), ACTN4(1), AKT3(1), BRAF(1), COL11A2(4), COL1A2(2), COL3A1(1), COL4A1(1), COL5A1(1), COL5A3(2), COL6A3(2), COMP(1), EGFR(1), ERBB2(1), FLNA(2), FLNC(1), FN1(2), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), ITGAV(1), LAMA1(2), LAMA2(1), LAMA4(1), LAMA5(1), LAMB1(1), LAMB2(1), LAMB3(1), MAPK1(3), PAK2(1), PAK3(1), PDGFC(1), PIK3CD(1), PIK3CG(1), PIK3R1(1), PPP1CB(1), PPP1R12A(3), PRKCA(1), PTEN(2), PTK2(1), RELN(2), RHOA(1), ROCK1(3), ROCK2(2), SOS1(1), SOS2(1), TNC(2), TNXB(2), VWF(1)20443356732771182272831301.69e-060.00052
3HSA04320_DORSO_VENTRAL_ AXIS_FORMATIONGenes involved in dorso-ventral axis formationBRAF, CPEB1, EGFR, ERBB2, ERBB4, ETS1, ETS2, ETV6, ETV7, FMN2, GRB2, KRAS, MAP2K1, MAPK1, MAPK3, NOTCH1, NOTCH2, NOTCH3, NOTCH4, PIWIL1, PIWIL2, PIWIL3, PIWIL4, RAF1, SOS1, SOS2, SPIRE1, SPIRE228BRAF(1), EGFR(1), ERBB2(1), FMN2(1), KRAS(1), MAPK1(3), NOTCH1(6), NOTCH2(2), NOTCH4(1), PIWIL1(2), PIWIL3(1), PIWIL4(2), SOS1(1), SOS2(1)291704424172232881500.0000140.0028
4NOTCHPATHWAYProteolysis and Signaling Pathway of NotchADAM17, DLL1, FURIN, NOTCH1, PSEN1, RBPSUH5ADAM17(1), DLL1(1), NOTCH1(6), PSEN1(2)5378401071020350200.0000440.0068
5HSA05130_PATHOGENIC_ ESCHERICHIA_COLI_ INFECTION_EHECGenes involved in pathogenic Escherichia coli infection - EHECABL1, ACTB, ACTG1, ARHGEF2, ARPC5, ARPC5L, CD14, CDC42, CDH1, CLDN1, CTNNB1, CTTN, EZR, FYN, HCLS1, ITGB1, KRT18, LOC643224, LOC654264, LY96, NCK1, NCK2, NCL, OCLN, PRKCA, RHOA, ROCK1, ROCK2, TLR4, TLR5, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB2C, TUBB3, TUBB4, TUBB4Q, TUBB6, TUBB8, WAS, WASL, YWHAQ, YWHAZ51ABL1(1), ARHGEF2(2), ARPC5(1), CTTN(1), EZR(1), LY96(1), PRKCA(1), RHOA(1), ROCK1(3), ROCK2(2), TUBA1C(1), TUBA3C(1), TUBA8(1), TUBB4(1), YWHAZ(1)289760419131982381500.000150.015
6HSA05131_PATHOGENIC_ ESCHERICHIA_COLI_ INFECTION_EPECGenes involved in pathogenic Escherichia coli infection - EPECABL1, ACTB, ACTG1, ARHGEF2, ARPC5, ARPC5L, CD14, CDC42, CDH1, CLDN1, CTNNB1, CTTN, EZR, FYN, HCLS1, ITGB1, KRT18, LOC643224, LOC654264, LY96, NCK1, NCK2, NCL, OCLN, PRKCA, RHOA, ROCK1, ROCK2, TLR4, TLR5, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB2C, TUBB3, TUBB4, TUBB4Q, TUBB6, TUBB8, WAS, WASL, YWHAQ, YWHAZ51ABL1(1), ARHGEF2(2), ARPC5(1), CTTN(1), EZR(1), LY96(1), PRKCA(1), RHOA(1), ROCK1(3), ROCK2(2), TUBA1C(1), TUBA3C(1), TUBA8(1), TUBB4(1), YWHAZ(1)289760419131982381500.000150.015
7HSA04530_TIGHT_JUNCTIONGenes involved in tight junctionACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, AMOTL1, ASH1L, CASK, CDC42, CDK4, CGN, CLDN1, CLDN10, CLDN11, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN2, CLDN20, CLDN22, CLDN23, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9, CRB3, CSDA, CSNK2A1, CSNK2A2, CSNK2B, CTNNA1, CTNNA2, CTNNA3, CTNNB1, CTTN, EPB41, EPB41L1, EPB41L2, EPB41L3, EXOC3, EXOC4, F11R, GNAI1, GNAI2, GNAI3, HCLS1, HRAS, IGSF5, INADL, JAM2, JAM3, KRAS, LLGL1, LLGL2, MAGI1, MAGI2, MAGI3, MLLT4, MPDZ, MPP5, MRAS, MRCL3, MRLC2, MYH1, MYH10, MYH11, MYH13, MYH14, MYH15, MYH2, MYH3, MYH4, MYH6, MYH7, MYH7B, MYH8, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLPF, NRAS, OCLN, PARD3, PARD6A, PARD6B, PARD6G, PPM1J, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R2A, PPP2R2B, PPP2R2C, PPP2R3A, PPP2R3B, PPP2R4, PRKCA, PRKCB1, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PTEN, RAB13, RAB3B, RHOA, RRAS, RRAS2, SPTAN1, SRC, SYMPK, TJAP1, TJP1, TJP2, TJP3, VAPA, YES1, ZAK130ACTN1(1), ACTN3(1), ACTN4(1), AKT3(1), AMOTL1(1), ASH1L(2), CGN(1), CLDN18(1), CTNNA1(1), CTNNA2(2), CTNNA3(2), CTTN(1), EPB41(1), GNAI2(1), KRAS(1), LLGL2(1), MAGI1(1), MAGI2(1), MYH1(3), MYH10(2), MYH11(1), MYH13(1), MYH14(2), MYH15(2), MYH2(1), MYH3(1), MYH6(3), MYH7(1), MYH7B(1), MYH8(3), MYH9(5), PARD3(1), PPM1J(1), PPP2R1A(1), PPP2R3A(1), PRKCA(1), PTEN(2), RHOA(1), SPTAN1(2)10681812572357184172151000.000400.032
8PS1PATHWAYPresenilin is required for gamma-secretase activity to activate Notch signaling; presenilin also inhibits beta-catenin in the Wnt/Frizzled pathway.ADAM17, APC, AXIN1, BTRC, CTNNB1, DLL1, DVL1, FZD1, GSK3B, NOTCH1, PSEN1, RBPSUH, TCF1, WNT112ADAM17(1), APC(3), DLL1(1), NOTCH1(6), PSEN1(2)11747161391320461200.000420.032
9ST_TYPE_I_INTERFERON_ PATHWAYType I interferon is an antiviral cytokine that induces a JAK-STAT type pathway leading to ISGF3 activation and a cellular antiviral response.IFNAR1, IFNB1, ISGF3G, JAK1, PTPRU, REG1A, STAT1, STAT2, TYK28IFNAR1(1), REG1A(1), STAT1(2), TYK2(3)68428877710331000.000520.035
10ST_INTEGRIN_SIGNALING_ PATHWAYIntegrins are transmembrane receptors that mediate cell growth, survival, and migration by binding to ligands in the extracellular matrix.ABL1, ACK1, ACTN1, ACTR2, ACTR3, AKT1, AKT2, AKT3, ANGPTL2, ARHGEF6, ARHGEF7, BCAR1, BRAF, CAV1, CDC42, CDKN2A, CRK, CSE1L, DDEF1, DOCK1, EPHB2, FYN, GRAF, GRB2, GRB7, GRF2, GRLF1, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGB3BP, MAP2K4, MAP2K7, MAP3K11, MAPK1, MAPK10, MAPK8, MAPK8IP1, MAPK8IP2, MAPK8IP3, MAPK9, MRAS, MYLK, MYLK2, P4HB, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PIK3CA, PIK3CB, PKLR, PLCG1, PLCG2, PTEN, PTK2, RAF1, RALA, RHO, ROCK1, ROCK2, SHC1, SOS1, SOS2, SRC, TERF2IP, TLN1, TLN2, VASP, WAS, ZYX77ABL1(1), ACTN1(1), AKT3(1), ARHGEF6(1), BRAF(1), EPHB2(1), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), MAPK1(3), PAK2(1), PAK3(1), PLCG2(1), PTEN(2), PTK2(1), ROCK1(3), ROCK2(2), SOS1(1), SOS2(1)6644340281826911261800.000570.035

(click for full table with 616 genesets)

Notes: (Please see notes under significantly mutated gene table)